Bee pollen has been used as a food supplement and as a traditional medicine for thousands of years. Our study demonstrated that by in vitro sister chromatid exchange assay, Mimosa pudica crude bee pollen extract (0.005-5.0 µg/mL CE) from Chiangmai, Northern Thailand, increased genotoxicity in human lymphocytes at concentrations of 0.005 and 0.5 µg/mL by 20% and 24% respectively, compared to the RPMI control. Its defatted extract (DE) at 0.005-5.0 µg/mL increased the activities by 24-32% whereas the lipid extract (LE) at 0.00125 µg/mL but not at 0.0125-1.25 µg/mL increased the activities by 25%. Only CE at 5.0 µg/mL induced cytotoxicity. Pretreatments of CE, DE, and LE at 0.5, 5, and 0.00125 µg/mL induced antigenotoxicities against doxorubicin, a potent genotoxic chemotherapeutic agent by 24%, 28%, and 16%, respectively. Their protective mechanisms are feasibly involved with α-tocopherol and phenolic contents such as gallic acid and ferulic acid.
Bee pollen is an apicultural product with a high nutritional value containing various phenolic compounds, vitamins, minerals, essential fatty acids, and proteins. It has traditionally been used as a food supplement for strengthening the body and as medicine to treat chronic prostatitis, gastric ulcer, and burn wounds [1, 2] . Bee pollen extract has antioxidant activity [3] , and its steroid fraction also promoted antitumor activity [4] . There is significant variation in the nutritional composition of bee pollen, associated with landscape composition [5] . To verify the chemical and biological activities of bee pollen from Thailand, we evaluated the chemical composition, genotoxic and antigenotoxic activities of commercial Mimosa pudica L. bee pollen collected from Chiangmai, Northern Thailand. The chemical composition were analyzed, including vitamin E (α-tocopherol) and phenolic compounds: gallic acid, ferulic acid, and sinapic acid. Doxorubicin (DXR) is a potent genotoxic chemotherapeutic agent [6] , acting through oxidative DNA damage [7] and acts as a DNA topoisomerase II inhibitor [8] . We measured the antigenotoxicity of bee pollen extracts against DXR in human lymphocytes by in vitro sister chromatid exchange (SCE) assay, as well as bee pollen extracts' genotoxicity. Cytotoxicity, cell proliferation index and cell cycle progression were also assessed.
Chemical compositions of crude bee pollen (CE), defatted extract (DE) and Lipid extract (LE): Bee pollen sample was extracted with diethyl ether in a Soxhlet apparatus giving 11.3+2.6 g% the lipid extract (LE) and 84.7+1.8 g% the defatted extract (DE). The bee pollen sample had pH 6.5 with 55 g% carbohydrate, 26 g% protein, 11 g% lipid, 1.7 g% fiber. In comparison to other countries, bee pollen from Thailand had similar nutritional values as from Portugal [9] , South Africa [10] and India [11] . However, the lipid content in Thai bee pollen was almost twice as high as those from Portugal and South Africa but similar to that from India. The phenolic and flavonoid contents in the DE were 9-fold and 2-fold higher than those in the LE, respectively (Table 1) . Total phenolic content in Thai bee pollen was similar to the content reported from Brazil [12] and Turkey [13] . Gallic acid and sinapic acid in the DE were 1.8-fold and 2-fold higher than those in the LE ( Table 2 ). The ferulic acid in the LE, however, was notably high, 14-fold higher compared to the DE. Only the LE had α-tocopherol.
Cytotoxicity and genotoxicity of CE, DE, and LE in human lymphocytes by in vitro SCE assay: CE at 5 µg/mL induced cytotoxicity as few mitotic cells were observed. CE at 0.005 and 0.5 µg/mL significantly increased genotoxicity as shown by the increase in SCE levels by 21% and 24% respectively, compared to the negative control RPMI (p<0.05). The 2% V/V DMSO solvent control tended to have slight increase in genotoxicity but no significant difference from that of the RPMI. DXR at 0.1 µg/mL, the positive control, significantly increased the SCE levels by 45%. DE at all concentrations (0.005-5 µg/mL) significantly induced genotoxicity by 24-32%. Only at the lowest concentration of 0.00125 µg/mL did LE significantly increase genotoxicity by 25%, whereas higher doses (0.0125-1.25 µg/mL) did not. (7) 2017 Ratanavalachai et al.
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Effects of CE, DE, and LE on cell proliferation and cell cycle kinetics:
No statistically significant difference in the mitotic index (M.I.) and proliferation index (P.I.) of CE, DE, LE treatments, and 2%V/V DMSO solvent control were observed when compared to the DXR positive control or RPMI negative control ( Table 3 ). All treated cells were normally grown into the second phase of the cell cycle in which the metaphase cells in the second cell cycle (MII) were highly detected. 
Antigenotoxicity of CE, DE and LE pretreatments against DXR:
As shown in Figure 1 , only the 0.5 µg/mL CE pretreatment significantly decreased DXR-induced SCE level by 26% as compared to the DXR alone (p<0.05). DE pretreatment only at the highest concentration of 5.0 µg/mL decreased DXR-induced SCE level by 28% (p<0.05) ( Figure 2) . Unexpectedly, LE pretreatment only at the lowest concentration of 0.00125 µg/mL decreased DXRinduced SCE level by 16% (p<0.05), whereas higher concentrations of LE (0.0125-1.25 µg/mL) did not ( Figure 3) .
Effects of CE, DE, and LE pretreatments followed by DXR on cell proliferation and cell cycle kinetics:
The mitotic index and proliferation index of CE, LE, and DE pretreatments at all concentrations, as well as those of the negative controls, RPMI and 2%V/V DMSO, had no significant differences from that of the DXR treatment alone (Table 4) . However, when the effects of those pretreatments were further analyzed for cell cycle kinetics, there was a tendency of increasing the number of metaphase cells in the first cell cycle (MI) at the lowest concentrations of CE, DE, and LE pretreatments, indicating cell cycle delay (Figure 4a,b,c) . On the contrary, CE, DE, and LE pretreatments at the specific doses of 0.5, 5, and 0.00125 µg/mL which induced antigenotoxicity against DXR, had a tendency to enhance cell proliferation (high MII cells). However, the 2% V/V DMSO pretreatment induced cell cycle delay. Its MI cells were substantially higher compared to those in MII cells. This could also be the effect of DMSO interaction with DXR but not DMSO alone. Mimosa pudica L. bee pollen from Thailand was revealed to be rich in lipids, proteins, vitamin E and phenolic content. Cytotoxic studies showed that only CE at 5 µg/mL induced cytotoxicity to human cells whereas LE at 1.2 µg/mL and DE at 5 µg/mL did not. DE at 5 µg/mL, LE at 0.0125 µg/mL, and CE at 0.5 µg/mL significantly increased SCE levels by 28%, 25%, and 24%, respectively. They also decreased DXR-induced SCE levels by 28%, 16%, and 26%, respectively. The phenolic contents, such as ferulic acid and gallic acid, and vitamin E in bee pollen extracts possibly play a major role in protecting cells from DXR-induced
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Natural Product Communications Vol. 12 (7) 2017 1113 genetic damage. Previous reports indicated that ferulic acid, protected rats from 7,12-dimethylbenz[a]anthracene induced genotoxicity [14] . Vitamin E and selenium reduced the chromosome damage induced by carbon tetrachloride in ovine peripheral lymphocytes [15] . Gallic acid protected against DXRinduced testicular and epididymal toxicity in a rat model [16] . In addition, DXR's mechanism of action induces oxidative DNA damage [7] . Therefore, the protective effects of bee pollen extracts against DXR possibly due to their phenolic and vitamin E contents possessing antioxidant activities.
Nonetheless, the effective low dose of LE pretreatments, as opposed to the high doses of DE or CE pretreatments, protecting against DXR-induced genotoxicity might involve additional mechanisms.
We postulate its weak genotoxic property possibly induced cellular adaptive response in stimulating the defensive system to protect cells from subsequent aggressive genotoxicant exposure. Examples of the adaptive responses might be in promoting antioxidant and anti-inflammatory activities. As a result, when adapted cells were later challenged with genotoxicants e.g. DXR, cells were already prepared and were able to protect cells from the DXR-induced damage. Maruyama et al., 2010 demonstrated that ethanolic extract of Spanish bee pollen had a potent anti-inflammatory activity in rats [17] . Tohamy et al., 2014 verified the antioxidant activity of Egyptian bee pollen in cisplatin-induced testicular toxicity in mice [18] . Therefore, both LE and DE at specific doses could cooperatively induce antigenotoxicity.
In conclusion, all CE, DE, and LE pretreatments significantly protected human cells from DXR-induced genotoxicity, possibly due to their high phenolic and vitamin E contents. Further, molecular mechanistic studies on genoprotective effects of bee pollen extracts would be useful to determine the optimum dose for health benefits.
Experimental
Plant materials: Mimosa pudica L. bee pollen was purchased from an apiary farm located in Chiangmai, Northern Thailand. The product was certified by Food and Drug Administration, the Ministry of Public Health, Thailand.
Analysis of the composition profile of bee pollen:
The lipid content was extracted by Soxhlet apparatus and analyzed. The protein content was analyzed by Kjeldahl method [19] . Ash and moisture contents were determined followed AOAC method [20] . The carbohydrate content was evaluated by calculation from 100-(protein+lipid+fiber+moisture+ash). Total flavonoids and total phenolic contents were analyzed by aluminum chloride colorimetric assay and Folin-Ciocalteu method, respectively [21] . Alpha-tocopherol, ferulic acid, sinapic acid and gallic acid were analyzed by quantitative high performance liquid chromatography (HPLC) [22a].
Sister chromatid exchange assay in human lymphocytes: The experiment was approved by the Institutional Ethics Committee (MTU-EC-DS-6-030/58).
Preparation of samples:
Each of the crude bee pollen and the lipid fraction was mixed with dimethylsulfoxide (DMSO) for an hour and then centrifuged. The supernatant was then mixed with RPMI for another hour resulting in the stock solution of crude bee pollen extract (CE) or lipid extract (LE). For a defatted fraction, it was directly solubilized in RPMI medium and called the defatted extract (DE).
Genotoxic studies: Human lymphocytes were cultured for 24 h in culture medium containing RPMI1640 (Hyclone, USA), fetal bovine serum albumin (Hyclone, USA), autologous plasma, penicillin-streptomycin (Seromed, Germany), L-glutamine (Hyclone, USA) and phytohemagglutinin (Seromed, Germany) using standard blood culture conditions as previously described [22b]. The lymphocyte cultures were then centrifuged for packed cells, and the supernatant medium was removed and saved for reuse after treatments. The remaining lymphocytes were treated with various concentrations of CE or LE or DE for 3 h. DXR, a genotoxic chemotherapeutic compound at 0.1 µg/mL was used as a positive control. Finally, lymphocyte cultures were centrifuged for packed cells. The supernatant medium was discarded, and the previously saved culture medium was reused. Bromodeoxyuridine (BrdU) solution (Sigma-Aldrich, USA) was added to the medium for the final concentration at 5 mM, and cell culture was continued at 37 o C in the dark. Cell harvesting was performed at 72 h after initiation. Fluorescent plus Giemsa technique was performed for staining and only cells having the second metaphase staining (MII phase) were analyzed for the frequencies of SCEs.
Antigenotoxic studies: Human lymphocytes were cultured for 24 h. At 24 h after initiation of the lymphocyte culture, the supernatant was removed and saved. The remaining lymphocyte cultures were treated with various concentrations of CE or LE or DE in RPMI 1640 culture medium for 2 h at 37 o C, centrifuged, and the supernatant medium was discarded. Then, the cells were further treated with DXR solution (0.1 µg/mL) for 2 h at 37 o C. After that, the lymphocytes were collected by centrifugation and discarding of the supernatant medium. The treated lymphocytes continued to be cultured at 37 o C in the dark with the previously saved medium, and BrdU solution was added to the final concentration at 5 mM. Cells were harvested at 77 h after initiation because of cell cycle delay. The Fluorescent plus Giemsa technique was also performed for staining.
Three independent experiments for each genotoxic/antigenotoxic studies were performed. In cell scoring, twenty-five cells per dose per experiment showing second metaphase staining pattern were scored from coded slides for the frequency of SCEs. Mitotic indices determined as the total number of mitotic cells/1,000 cells and proliferation indices determined as (MI + 2MII + 3MIII)/100 cells were evaluated. MI, MII, and MIII are the number of mitotic cells in the first cell cycle, second cell cycle and the third cell cycle, respectively.
Statistical analysis: Raw data obtained from SCE assays were transformed to stabilize the variance by the procedures of Whorton et al, 1984 [22c] as following:-Transformed SCE (SCE T ) = square root SCE
